Clinical trials: Benign Blood Diseases
Prostatic Hyperplasia, Hypertension
Does Benign Prostatic Obstruction Cause Hypertension?
The known correlation between benign prostatic hypertrophy (BPH) and hypertension could be explained by 3 theoretical pathway models.
- Trial name
- NCT02347436
- Testing
- 24-hr ambulatory blood pressure measurement
- Where
- Norway
- Volunteers
- 20 people
- Sponsor
- St. Olavs Hospital
Cancer, Liver Cirrhosis
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
To acquire blood samples from subjects for various purposes, including: i) determining the sensitivity and specificity of select DNA methylation markers for the detection of various types of cancer, ii) identifying benign…
- Conditions
- Cancer, Liver Cirrhosis, Chronic Hepatitis, Hepatitis B
- Trial name
- ELITE (NCT05181826)
- Testing
- Multi-analyte Blood Test
- Where
- 7 sites in United States
- Volunteers
- 1,200 people
- Sponsor
- Helio Genomics
Borrelia; Infection, Burgdorferi (Erythema Chronicum Migrans)
Sofia 2 Lyme FIA Whole Blood Clinical Study
The objective of this study is to demonstrate the clinical performance of the Sofia® 2 analyzer and Sofia Lyme FIA test in the CLIA waived test environment in comparison to Comparator Method(s) and/or an FDA cleared predicate…
- Trial name
- NCT03238274
- Testing
- Sofia 2 Lyme FIA testing
- Where
- 11 sites in United States
- Volunteers
- 597 people
- Sponsor
- Quidel Corporation
Benign Prostatic Hyperplasia, Transurethral Resection of the Prostate
Intraprostatic Injection of Tranexamic Acid Decrease Blood Loss During Monopolar TURP
This study aims to assess the role of intraprostatic injection of tranexamic acid in decreasing the blood loss during Transurethral resection of the prostate.
- Conditions
- Benign Prostatic Hyperplasia, Transurethral Resection of the Prostate, Tranexamic Acid
- Trial name
- NCT05913466
- Testing
- Tranexamic Acid group, Distilled water group
- Volunteers
- 60 people
- Sponsor
- Benha University
Hepatectomy
Use of Transcollation Device to Decrease Blood Loss During Hepatic Resections: a Randomized Cohort Study (HEPACOLL)
Blood loss in hepatic surgery is the main factor of postoperative morbidity. The use of the most effective possible tool for hemostasis allows a bleeding decrease during liver transection and thus could reduce postoperative…
- Trial name
- NCT01874639
- Testing
- standard bipolar coagulation, Aquamantys® probe for liver hemostasis
- Where
- France
- Volunteers
- 140 people
- Sponsor
- University Hospital, Clermont-Ferrand
Breast Cancer
Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease
RATIONALE: Collecting and storing samples of blood and tumor tissue from patients with cancer to test in the laboratory may help the study of cancer in the future.
- Trial name
- NCT00898508
- Testing
- gene expression analysis, mutation analysis, proteomic profiling
- Where
- 3 sites in United States
- Volunteers
- 563 people
- Sponsor
- City of Hope Medical Center
Liver Disease
Randomised Prospective Study of CUSA Versus Radiofrequency Ablation Technique in Liver Resections
The purpose of this study is to determine whether a particular method of operating on the liver is superior to the "gold" standard commonest technique.
- Trial name
- NCT06980571
- Testing
- radiofrequency ablation
- Where
- United Kingdom
- Volunteers
- 100 people
- Sponsor
- Barts & The London NHS Trust